Alfresa Holdings Corporation (TYO:2784)
Japan · Delayed Price · Currency is JPY 2,299.00
+4.00 (0.17%)
Nov 13, 2026, 3:30 PM JST
Alfresa Holdings Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,157,062 | 3,104,064 | 2,961,051 | 2,858,500 | 2,696,069 | 2,585,643 |
Revenue Growth | 4.04% | 4.83% | 3.59% | 6.02% | 4.27% | -0.67% |
Gross Profit Gross Profit Growth | 218,277 | 217,881 | 213,928 | 206,372 | 192,086 | 187,469 |
Operating Income Operating Income Growth | 32,846 | 36,022 | 38,082 | 38,462 | 30,149 | 29,092 |
Net Income Net Income Growth | 38,465 | 41,746 | 27,389 | 29,558 | 25,786 | 32,182 |
Earnings Per Share EPS Growth | 214.40 | 229.64 | 147.54 | 154.13 | 127.42 | 153.57 |
EPS Growth | 58.02% | 55.65% | -4.27% | 20.96% | -17.03% | 32.67% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dispensing Pharmacy Business Dispensing Pharmacy Business Growth | 37,831 | 37,174 | 37,023 | 36,654 | 36,202 | 34,468 |
Unallocated Adjustment Unallocated Adjustment Growth | -35,074 | -34,949 | -35,834 | -33,670 | -31,213 | -29,109 |
Self-Medication Wholesale Business Self-Medication Wholesale Business Growth | 262,103 | 267,074 | 265,748 | 262,843 | 246,679 | 244,822 |
Pharmaceutical Manufacturing Business Pharmaceutical Manufacturing Business Growth | 50,492 | 52,179 | 54,065 | 52,740 | 49,041 | 47,359 |
Pharmaceutical Products Wholesale Segment Pharmaceutical Products Wholesale Segment Growth | 2,840,479 | 2,782,584 | 2,640,048 | 2,539,932 | 2,395,358 | 2,288,102 |
Total Total Growth | 3,157,059 | 3,104,062 | 2,961,050 | 2,858,499 | 2,696,067 | 2,585,642 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 198,679 | 193,066 | 177,085 | 213,756 | 160,122 | 180,436 |
Total Debt Total Debt Growth | 30,000 | 35,620 | 35,545 | 34,937 | 3,855 | 5,039 |
Net Cash (Debt) Net Cash Growth | 168,679 | 157,446 | 141,540 | 178,819 | 156,267 | 175,397 |
Net Cash Growth | 8.52% | 11.24% | -20.85% | 14.43% | -10.91% | 6.84% |
Net Cash Per Share Net Cash Per Share Growth | 940.19 | 866.11 | 762.46 | 932.43 | 772.19 | 836.99 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 44,523 | 38,566 | 5,639 | 86,379 | 13,086 | 36,546 |
Capital Expenditures CapEx Growth | -16,221 | -22,457 | -16,508 | -12,737 | -22,716 | -15,002 |
Free Cash Flow Free Cash Flow Growth | 28,302 | 16,109 | -10,869 | 73,642 | -9,630 | 21,544 |
Free Cash Flow Growth | 118.18% | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 6.91% | 7.02% | 7.22% | 7.22% | 7.12% | 7.25% |
Operating Margin | 1.04% | 1.16% | 1.29% | 1.35% | 1.12% | 1.13% |
Pretax Margin | 1.84% | 2.00% | 1.33% | 1.53% | 1.43% | 1.86% |
Profit Margin | 1.22% | 1.34% | 0.92% | 1.03% | 0.96% | 1.24% |
FCF Margin | 0.90% | 0.52% | -0.37% | 2.58% | -0.36% | 0.83% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 71.000 | 68.000 | 63.000 | 60.000 | 57.000 | 54.000 |
Dividend Per Share Growth | 4.41% | 7.94% | 5.00% | 5.26% | 5.56% | 1.89% |
Dividend Yield | 3.09% | 2.69% | 2.98% | 2.70% | 3.36% | 3.18% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 10.72 | 11.00 | 14.02 | 14.05 | 13.31 | 10.68 |
Forward PE | 16.23 | 14.84 | 12.92 | 17.47 | 13.91 | 16.46 |
P/FCF Ratio | 14.25 | 28.52 | - | 5.64 | - | 15.96 |
PS Ratio | 0.13 | 0.15 | 0.13 | 0.14 | 0.13 | 0.13 |